Antiangiogenic agents: current limits in thoracic oncology

被引：0
|
作者：
Dansin, Eric [1 ]
Lauridant, Geraldine [1 ]
Chahine, Bachar [1 ]
机构：
[1] CLCC Oscar Lambret, Dept Cancerol Gen, F-59020 Lille, France
来源：
BULLETIN DU CANCER | 2012年 / 99卷 / 11期
关键词：
antiangiogenic agent; multi-targeted tyrosine kinase inhibitor; bevacizumab; lung cancer; thoracic oncology; CELL-LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; RANDOMIZED PHASE-II; ANGIOGENESIS INHIBITOR BEVACIZUMAB; ARTERIAL THROMBOEMBOLIC EVENTS; PACLITAXEL PLUS BEVACIZUMAB; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; COST-EFFECTIVENESS; 1ST-LINE BEVACIZUMAB;
D O I：
10.1684/bdc.2012.1655
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Antiangiogenic agents appear as major therapeutic options in renal, colorectal and breast cancer. Their part in thoracic oncology is still limited today except for bevacizumab. We review the current limits of antiangiogenic agents in terms of efficacy, activity, tolerance and therapeutic strategies. Problems about predictive biomarkers and cost-effectiveness of antiangiogenic agents in thoracic oncology are also mentioned.
引用
收藏
页码：1083 / 1091
页数：9
相关论文
共 50 条
  • [21] Antiangiogenic Therapies: Going beyond Their Limits
    Moserle, Lidia
    Jimenez-Valerio, Gabriela
    Casanovas, Oriol
    CANCER DISCOVERY, 2014, 4 (01) : 31 - 41
  • [22] Novel antiangiogenic agents in dermatology
    Berrios, Ricardo L.
    Arbiser, Jack L.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 508 (02) : 222 - 226
  • [23] Antiangiogenic Agents in Multiple Myeloma
    Kumar, Shaji
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S44 - S45
  • [24] Beyond Bevacizumab: Antiangiogenic Agents
    Rogosin, Shane
    Sandler, Alan B.
    CLINICAL LUNG CANCER, 2012, 13 (05) : 326 - 333
  • [25] Antiangiogenic agents and gastrointestinal cancers
    Lievre, A.
    Landi, B.
    Mitry, E.
    Taieb, J.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 504 - 520
  • [26] The thoracic oncology specialist: curriculum recommendations in thoracic oncology training
    Meert, Anne-Pascale
    Noel, Julie-Lyn
    Gamarra, Fernando
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 628 - 631
  • [27] Antiangiogenic agents for the treatment of glioblastoma
    Gerstner, Elizabeth R.
    Duda, Dan G.
    di Tomaso, Emmanuelle
    Sorensen, Greg
    Jain, Rakesh K.
    Batchelor, Tracy T.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (12) : 1895 - 1908
  • [28] Molecular imaging of antiangiogenic agents
    Rehman, S
    Jayson, GC
    ONCOLOGIST, 2005, 10 (02): : 92 - 103
  • [29] Antiangiogenic agents and targets: A perspective
    Teicher, Beverly A.
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (01) : 6 - 12
  • [30] A patent perspective of antiangiogenic agents
    Zhang, Junyu
    Wang, Jin
    Li, Yanchen
    Pan, Xiaoyan
    Qu, Jingkun
    Zhang, Jie
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2023, 33 (12) : 821 - 840
12345